DK3972974T3 - Stabil polymorf form af 6-fluor-9-methyl-9H-ß-carbolin og anvendelser deraf - Google Patents
Stabil polymorf form af 6-fluor-9-methyl-9H-ß-carbolin og anvendelser deraf Download PDFInfo
- Publication number
- DK3972974T3 DK3972974T3 DK20751166.8T DK20751166T DK3972974T3 DK 3972974 T3 DK3972974 T3 DK 3972974T3 DK 20751166 T DK20751166 T DK 20751166T DK 3972974 T3 DK3972974 T3 DK 3972974T3
- Authority
- DK
- Denmark
- Prior art keywords
- carboline
- fluoro
- methyl
- polymorphic form
- stable polymorphic
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/13—Crystalline forms, e.g. polymorphs
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP19191150.2A EP3772515A1 (en) | 2019-08-09 | 2019-08-09 | Stable polymorphic form of 6-fluoro-9-methyl-9h-ss-carboline and uses thereof |
| PCT/EP2020/072328 WO2021028365A1 (en) | 2019-08-09 | 2020-08-07 | Stable polymorphic form of 6-fluoro-9-methyl-9h-b-carboline and uses thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK3972974T3 true DK3972974T3 (da) | 2024-11-25 |
Family
ID=67614427
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK20751166.8T DK3972974T3 (da) | 2019-08-09 | 2020-08-07 | Stabil polymorf form af 6-fluor-9-methyl-9H-ß-carbolin og anvendelser deraf |
Country Status (18)
| Country | Link |
|---|---|
| US (1) | US12466824B2 (da) |
| EP (2) | EP3772515A1 (da) |
| JP (1) | JP7337254B2 (da) |
| CN (1) | CN114269743B (da) |
| AU (1) | AU2020329535B2 (da) |
| BR (1) | BR112022001433A2 (da) |
| CA (1) | CA3143605A1 (da) |
| CL (1) | CL2022000225A1 (da) |
| CU (1) | CU24716B1 (da) |
| DK (1) | DK3972974T3 (da) |
| ES (1) | ES3003258T3 (da) |
| IL (1) | IL290272B1 (da) |
| MX (1) | MX2022001566A (da) |
| MY (1) | MY206963A (da) |
| PH (1) | PH12021553191A1 (da) |
| PL (1) | PL3972974T3 (da) |
| WO (1) | WO2021028365A1 (da) |
| ZA (1) | ZA202201719B (da) |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20040038970A1 (en) | 1998-06-12 | 2004-02-26 | Societe De Conseils De Recherches Etd' Application Scientifiques, S.A.S. A Paris, France Corp. | Beta-carboline compounds |
| DE102007009264A1 (de) | 2007-02-26 | 2008-08-28 | Ellneuroxx Ltd. | 9-Alkyl-ß-Carboline zur Behandlung von neurodegenerativen Erkrankungen |
| BR112012015967B1 (pt) * | 2009-12-28 | 2019-08-27 | Audiocure Pharma Gmbh | uso de compostos de fórmula geral (i) e composição farmacêutica |
| EP2853533A1 (de) * | 2013-09-29 | 2015-04-01 | Audiocure Pharma GmbH | 6-Fluor-9-methyl-ß-carbolin |
-
2019
- 2019-08-09 EP EP19191150.2A patent/EP3772515A1/en not_active Withdrawn
-
2020
- 2020-08-07 DK DK20751166.8T patent/DK3972974T3/da active
- 2020-08-07 CN CN202080056545.8A patent/CN114269743B/zh active Active
- 2020-08-07 PL PL20751166.8T patent/PL3972974T3/pl unknown
- 2020-08-07 CU CU2022000008A patent/CU24716B1/es unknown
- 2020-08-07 MX MX2022001566A patent/MX2022001566A/es unknown
- 2020-08-07 AU AU2020329535A patent/AU2020329535B2/en active Active
- 2020-08-07 ES ES20751166T patent/ES3003258T3/es active Active
- 2020-08-07 MY MYPI2022000510A patent/MY206963A/en unknown
- 2020-08-07 BR BR112022001433A patent/BR112022001433A2/pt unknown
- 2020-08-07 IL IL290272A patent/IL290272B1/en unknown
- 2020-08-07 JP JP2022508884A patent/JP7337254B2/ja active Active
- 2020-08-07 EP EP20751166.8A patent/EP3972974B1/en active Active
- 2020-08-07 WO PCT/EP2020/072328 patent/WO2021028365A1/en not_active Ceased
- 2020-08-07 PH PH1/2021/553191A patent/PH12021553191A1/en unknown
- 2020-08-07 CA CA3143605A patent/CA3143605A1/en active Pending
- 2020-08-07 US US17/633,544 patent/US12466824B2/en active Active
-
2022
- 2022-01-27 CL CL2022000225A patent/CL2022000225A1/es unknown
- 2022-02-09 ZA ZA2022/01719A patent/ZA202201719B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| ZA202201719B (en) | 2023-11-29 |
| CL2022000225A1 (es) | 2022-09-09 |
| IL290272A (en) | 2022-04-01 |
| JP2022545361A (ja) | 2022-10-27 |
| MY206963A (en) | 2025-01-22 |
| US20220289741A1 (en) | 2022-09-15 |
| CN114269743B (zh) | 2023-11-10 |
| AU2020329535A1 (en) | 2022-01-20 |
| PL3972974T3 (pl) | 2025-03-10 |
| JP7337254B2 (ja) | 2023-09-01 |
| WO2021028365A1 (en) | 2021-02-18 |
| PH12021553191A1 (en) | 2022-10-24 |
| AU2020329535B2 (en) | 2025-06-26 |
| ES3003258T3 (en) | 2025-03-10 |
| CU24716B1 (es) | 2024-07-10 |
| MX2022001566A (es) | 2022-03-02 |
| CA3143605A1 (en) | 2021-02-18 |
| EP3772515A1 (en) | 2021-02-10 |
| CU20220008A7 (es) | 2022-09-08 |
| EP3972974B1 (en) | 2024-10-23 |
| CN114269743A (zh) | 2022-04-01 |
| EP3972974A1 (en) | 2022-03-30 |
| US12466824B2 (en) | 2025-11-11 |
| BR112022001433A2 (pt) | 2022-03-22 |
| IL290272B1 (en) | 2026-04-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK3595653T3 (da) | Sammensætninger af plinabulin og anvendelse heraf | |
| DK3963021T3 (da) | Stabiliserede fluorolefinsammensætninger og fremgangsmåder til anvendelse deraf | |
| DK3810581T3 (da) | Krystalmodifikationer af odevixibat | |
| DK3443000T3 (da) | Cd80-varianter af immunmodulerende proteiner og deres anvendelse | |
| DK4045039T3 (da) | Hæmning af human integrin-alfa4beta7 | |
| DK3877052T3 (da) | Pyridazinonforbindelser og anvendelser deraf | |
| DK3509581T3 (da) | Formuleringer af (r)-2-amino-3-phenylpropylcarbamat | |
| EP3843729A4 (en) | NOVEL COMPOSITIONS AND PROCESSES | |
| DK3781561T3 (da) | Modulatorer af methylmodificerende enzymer, sammensætninger og anvendelser deraf | |
| DK3877376T3 (da) | Pyridazinonforbindelser og anvendelser deraf | |
| DK3283107T3 (da) | Sammensætninger omfattende en kombination af ipilimumab og nivolumab | |
| DK3288553T3 (da) | Kombinationer af cannabinoider og n-acylethanolaminer | |
| JP2018172409A5 (ja) | １５−ｈｅｐｅを含む組成物および同組成物を使用する方法 | |
| DK3592337T3 (da) | Farmaceutiske formuleringer af phloroglucinol og trimethylphloroglucinol | |
| DK3574135T3 (da) | Fremgangsmåde og formulering til fremstilling af ligninfibre | |
| DK3943070T3 (da) | Langtidsvirkende formuleringer af bedaquilin | |
| DK3606929T3 (da) | Beta-nicotinat-ester-nukleotider og fremgangsmåder til fremstilling af samme | |
| DK3474822T3 (da) | Formuleringer af brincidofovir | |
| DK3697418T3 (da) | Forbedrede formuleringer af bromocriptin | |
| DK3595665T3 (da) | Dobbelthæmmere af magl og faah | |
| DK3347006T3 (da) | Deutererede analoger af etifoxin, derivater deraf og anvendelser deraf | |
| DK3707870T3 (da) | Gruppering og anvendelse af korte sekvenssignaler | |
| EP3630846A4 (en) | CELLULAR IMMUNOTHERAPY COMPOSITIONS AND PROCEDURES | |
| DK3445406T3 (da) | Sammensætninger og fremgangsmåder til forøget genekspression af pklr | |
| DK4223886T3 (da) | Sammensætninger og fremgangsmåder til stabilisering af mikro-rna |